257 related articles for article (PubMed ID: 28741988)
1. Comparison of Quality of Life in Patients with β-Thalassemia Intermedia and β-Thalassemia Major in Southern Iran.
Haghpanah S; Vahdati S; Karimi M
Hemoglobin; 2017 May; 41(3):169-174. PubMed ID: 28741988
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of depression and anxiety in adult patients with β-thalassemia major and intermedia.
Khoury B; Musallam KM; Abi-Habib R; Bazzi L; Ward ZA; Succar J; Halawi R; Hankir A; Koussa S; Taher AT
Int J Psychiatry Med; 2012; 44(4):291-303. PubMed ID: 23885513
[TBL] [Abstract][Full Text] [Related]
3. β-Thalassemia in Iran: Things Everyone Needs to Know About This Disease.
Hadipour Dehshal M; Tabrizi Namini M; Hantoushzadeh R; Yousefi Darestani S
Hemoglobin; 2019 May; 43(3):166-173. PubMed ID: 31272240
[TBL] [Abstract][Full Text] [Related]
4. β- and α-Thalassemia intermedia in Basra, Southern Iraq.
Abdulwahid DA; Hassan MK
Hemoglobin; 2013; 37(6):553-63. PubMed ID: 23944608
[TBL] [Abstract][Full Text] [Related]
5. Quality of Life and Depression in Turkish Patients with β-Thalassemia Major: A Cross-Sectional Study.
Töret E; Karadaş NÖ; Gökçe NÖ; Kaygusuz A; Karapınar TH; Oymak Y; Gözmen S
Hemoglobin; 2018; 42(5-6):326-329. PubMed ID: 30672351
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlation related to lipid profile in beta-thalassemia major and intermedia in southern Iran.
Bordbar M; Haghpanah S; Afrasiabi A; Dehbozorgian J; Karimi M
J Clin Lipidol; 2012; 6(2):108-13. PubMed ID: 22385543
[TBL] [Abstract][Full Text] [Related]
7. Quality of life among Iranian patients with beta-thalassemia major using the SF-36 questionnaire.
Haghpanah S; Nasirabadi S; Ghaffarpasand F; Karami R; Mahmoodi M; Parand S; Karimi M
Sao Paulo Med J; 2013; 131(3):166-72. PubMed ID: 23903265
[TBL] [Abstract][Full Text] [Related]
8. The diminishing trend of β-thalassemia in Southern Iran from 1997 to 2011: the impact of preventive strategies.
Joulaei H; Shahbazi M; Nazemzadegan B; Rastgar M; Hadibarhaghtalab M; Heydari M; Ghaffarpasand F; Rahimi N
Hemoglobin; 2014; 38(1):19-23. PubMed ID: 24274135
[TBL] [Abstract][Full Text] [Related]
9. Interaction of an α-Globin Gene Triplication with β-Globin Gene Mutations in Iranian Patients with β-Thalassemia Intermedia.
Farashi S; Bayat N; Faramarzi Garous N; Ashki M; Montajabi Niat M; Vakili S; Imanian H; Zeinali S; Najmabadi H; Azarkeivan A
Hemoglobin; 2015; 39(3):201-6. PubMed ID: 26084319
[TBL] [Abstract][Full Text] [Related]
10. Quality of Life Outcomes in a Pediatric Thalassemia Population in Egypt.
Adam S; Afifi H; Thomas M; Magdy P; El-Kamah G
Hemoglobin; 2017 Jan; 41(1):16-20. PubMed ID: 28440111
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Effect of Support-Training System of Peer Group on Promotion of Self-Care in β-Thalassemia Major Patients in Southern Iran.
Safaei S; Abedi H; Parand S; Karimi M
Hemoglobin; 2019 May; 43(3):198-203. PubMed ID: 31422722
[TBL] [Abstract][Full Text] [Related]
12. Complications of β-thalassemia intermedia in Iran during 1996-2010 (single-center study).
Rafsanjani KA; Mafi N; Tafreshi RI
Pediatr Hematol Oncol; 2011 Sep; 28(6):497-508. PubMed ID: 21728720
[TBL] [Abstract][Full Text] [Related]
13. Utility of the multivariate approach in predicting β-thalassemia intermedia or β-thalassemia major types In Iranian patients.
Banan M; Bayat H; Namdar-Aligoodarzi P; Azarkeivan A; Kamali K; Daneshmand P; Zaker-Kandjani B; Najmabadi H
Hemoglobin; 2013; 37(5):413-22. PubMed ID: 23805990
[TBL] [Abstract][Full Text] [Related]
14. Analysis of intelligence quotient in patients with homozygous beta-thalassemia.
Karimi M; Yarmohammadi H; Cappellini MD
Saudi Med J; 2006 Jul; 27(7):982-5. PubMed ID: 16830015
[TBL] [Abstract][Full Text] [Related]
15. Quality of Life of Pakistani Children with β-Thalassemia Major.
Yasmeen H; Hasnain S
Hemoglobin; 2018; 42(5-6):320-325. PubMed ID: 30700180
[TBL] [Abstract][Full Text] [Related]
16. Alterations of anticoagulant proteins and soluble endothelial protein C receptor in thalassemia patients of Chinese origin.
Huang Y; Long Y; Deng D; Liu Z; Liang H; Sun N; Xu Y; Lai Y; Cheng P
Thromb Res; 2018 Dec; 172():61-66. PubMed ID: 30384036
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting quality of life in children and adolescents with thalassemia in Iraqi Kurdistan.
Mikael NA; Al-Allawi NA
Saudi Med J; 2018 Aug; 39(8):799-807. PubMed ID: 30106418
[TBL] [Abstract][Full Text] [Related]
18. Health-related Quality of Life and Associated Factors Among Thalassemia Major Patients, Southeast of Iran.
Bazi A; Sargazi-Aval O; Safa A; Miri-Moghaddam E
J Pediatr Hematol Oncol; 2017 Oct; 39(7):513-517. PubMed ID: 28859037
[TBL] [Abstract][Full Text] [Related]
19. Molecular Characterization of β-Thalassemia Intermedia in Southeast Iran.
Miri-Moghaddam E; Bahrami S; Naderi M; Bazi A; Karimipoor M
Hemoglobin; 2016 Jun; 40(3):173-8. PubMed ID: 27117567
[TBL] [Abstract][Full Text] [Related]
20. Quality of life among adolescents aged 14 to 18 years with Beta-Thalassemia Major (TM) in Qatar.
Nashwan AJ; Yassin MA; Babu GDJ; Nair SLK; Libo-On IL; Hijazi HA; De Sanctis V; Soliman A
Acta Biomed; 2018 Feb; 89(2-S):16-26. PubMed ID: 29451225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
